You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Serratia marcescens antibody (ab35159)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Serratia marcescens antibody
See all Serratia marcescens products (2) ...

Description

Rabbit polyclonal to Serratia marcescens

Tested applications

ELISAmore details

Cross reactivity

Immunogen

LPS from Serratia marcescens.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: None
Constituents: Whole serum

Purity

Whole antiserum

Clonality

Polyclonal

Isotype

IgG

Applications

Show applications key

Our Abpromise guarantee covers the use of ab35159 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • ELISA

     

Application notes

ELISA: In a simple ELISA with 1 µg of antigen coated, the end point dilution for this antibody was observed at 1/32,000.

Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Relevance

Serratia marcescens is a species of Gram negative bacteria in the family Enterobacteriaceae. It is a broad host range pathogen, and is also capable of opportunistic infections of humans. Some strains of S. marcescens are capable of producing a pigment called prodigiosin, which ranges in color from dark red to pale pink. S. marcescens is a rod shaped, motile organism and can grow in temperatures ranging from 5 - 40°C Celsius and in pH levels ranging from 5 to 9. S. marcescens is involved in hospital-acquired infections, particularly in urinary tract and wound infections. Serratia species cause 1.4% of nosocomial bloodstream infections with an associated mortality of 25% [in USA]. Most S. marcescens strains are resistant to several antibiotics because of the presence of R factors in plasmids.

References for Anti-Serratia marcescens antibody (ab35159)

ab35159 has not yet been referenced specifically in any publications.

Publishing research using ab35159? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"